Livorno, Italy

Alessio Ramacciotti

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Menarini Richerche S.p.a.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alessio Ramacciotti. Retrieved from https://idiyas.com/inventor/alessio-ramacciotti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alessio Ramacciotti: Innovator in the Synthesis of Optically Active Anthracyclines

Introduction

Alessio Ramacciotti is a notable inventor based in Leghorn, Italy. He has made significant contributions to the field of chemistry, particularly in the synthesis of optically active anthracyclines. His innovative approach has led to advancements in pharmaceutical applications.

Latest Patents

Alessio holds a patent for a process titled "Process for the synthesis of optically active anthracyclines." This patent describes a method involving the key intermediate (R)2-acetyl-2-hydroxy-1,2,3,4-tetrahydronaphtalene 5,8-dialkoxy-3,4-dihydronaphtalene. The process includes steps such as acylation, asymmetric dihydroxylation, transformation into chloroacetate, dehydrochloridation, and final hydrolysis. He has 1 patent to his name.

Career Highlights

Alessio Ramacciotti is associated with Menarini Richerche S.p.a., where he applies his expertise in the synthesis of complex organic compounds. His work has been instrumental in developing new methodologies that enhance the efficiency and effectiveness of drug synthesis.

Collaborations

Alessio collaborates with talented professionals in his field, including Cristina Di Bugno and Fabio D'Arata. These partnerships foster innovation and contribute to the advancement of research in pharmaceutical chemistry.

Conclusion

Alessio Ramacciotti's contributions to the synthesis of optically active anthracyclines highlight his role as an influential inventor in the pharmaceutical industry. His innovative processes and collaborations continue to drive advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…